Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Mingjing Pharmaceutical is a pharmaceutical enterprise based in Kunming, Yunnan Province, China, focusing on the integration of Traditional Chinese Medicine (TCM) with modern pharmaceutical manufacturing. Founded in 1997, the company produces a wide range of dosage forms including tablets, capsules, and granules, targeting therapeutic areas such as respiratory health, pediatrics, and hepatology. Its operations are centered around its GMP-certified production base in the Xishan District of Kunming. The company is well-known in the regional market for its "Mingjing" brand products, which leverage Yunnan's rich botanical resources for herbal medicine production. Key products include treatments for pediatric cough, liver disorders, and inflammatory conditions. The firm is recognized as a High-tech Enterprise and plays a significant role in the modernization of ethnic medicines in Southwest China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yunnan Mingjing Pharmaceutical.